CX vs FRSH: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
CX is the larger of the two ($13.35B market cap): the incumbent the market prices for continued execution (10.35x forward earnings, beta 0.70). FRSH is the smaller challenger ($3.27B), actually pricier on forward earnings (14.31x): more room to run, but more to prove. If you believe in growth, FRSH fits: analysts expect its revenue to rise 14% next year, against 3% for CX. If you believe in paying less for profit, CX fits: it trades at 10.35x forward earnings, against 14.31x for FRSH.
CX vs FRSH: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CX | FRSH | What it tells you |
|---|---|---|---|
| Market cap | $13.35B | $3.27B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 10.35 | 14.31 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 57.81 | 17.29 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.70 | 0.76 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 1% of range | 65% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.04 | 3.56 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: CX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how CX and FRSH affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CX and FRSH share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CX and FRSH exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Cemex (CX) do?
Cemex (NYSE: CX) is a global building-materials company that makes and sells cement, ready-mix concrete, and aggregates (crushed stone, sand, and gravel), along with related urbanization and infrastructure products. It operates across five reportable segments (Mexico, the United States, Europe, the Middle East and Africa, and South, Central America and the Caribbean), with the US and Mexico together accounting for roughly 60% of 2025 revenue. The US-listed security is an ADR representing the underlying Mexican shares; the company is one of the largest cement producers in the world alongside Holcim, Heidelberg Materials, and CRH.
What does Freshworks (FRSH) do?
Freshworks Inc. (Nasdaq: FRSH) builds cloud software that helps companies run service and support functions. Its flagship products are Freshdesk (customer support), Freshservice (IT and employee service management), and a customer relationship management suite, all increasingly wrapped in its Freddy AI layer for automation, copilots, and AI agents. The company positions itself as an easier-to-deploy, lower-cost alternative to heavyweight incumbents, and has been steadily shifting upmarket: customers paying over $50,000 in annual recurring revenue grew about 22% year over year to roughly 3,900 as of Q1 2026 and now represent more than half of total ARR.
CX vs FRSH: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- CX drivers: US aggregates and infrastructure tilt; Margin self-help and efficiency programs.
- FRSH drivers: AI monetization through Freddy; Move upmarket to larger customers.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Cemex is a deeply cyclical business whose demand swings with construction and infrastructure spending, so a downturn or higher-for-longer interest rates could pressure volumes and pricing. For FRSH, revenue growth has decelerated from hypergrowth levels into the mid-teens (about 16% in the second quarter of 2026 and about 14% in the third, with fourth-quarter guidance also near 14%), and the shares fell about 20% in the month to November 20, 2026 even after an earnings beat, which shows how the market reacts to slowing growth.
CX or FRSH: which should you pick?
If the story you believe is CX's (US aggregates and infrastructure tilt), CX is the more direct way to own it; if it is FRSH's (AI monetization through Freddy), FRSH is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CX and FRSH guides.
CX vs FRSH: the full fundamentals
CX. Cemex trades around $9.24 per ADR with a trailing P/E near 58, still inflated by a fourth-quarter 2025 net loss, but a forward P/E near 10 and an EV/EBITDA of about 6.2, which point to expectations of rising earnings as efficiency programs and US aggregates flow through. The multiples have compressed further since October because the ADR fell while third-quarter results beat and leverage came down. The average of 15 analyst targets is about $14.77, and consensus for the fourth quarter is EPS near $0.14 on revenue near $4.24 billion.
FRSH. As of November 20, 2026 Freshworks traded around $12.46 per share for a market cap near $3.3 billion, roughly 3.5 times trailing revenue, a discount to many higher-growth SaaS peers. Trailing GAAP earnings are inflated by a large non-operating gain in the fourth quarter of 2025, so the trailing P/E of about 17 should be read with care; free cash flow of about $255 million is the steadier measure. Thirteen analysts have a mean price target near $16.69, and UBS raised its target to $17 from $14 after the third-quarter report.
Headline figures (approximate, November 2026): CX shows revenue (ttm) ~$17.4B (Q3 2026 +8% YoY), q3 2026 ebitda ~$990M (+12% YoY), q3 2026 eps ~$0.28 vs ~$0.21 consensus, net income (ttm) ~$688M (~3.6% profit margin); FRSH shows revenue (ttm) ~$934M, q3 2026 revenue ~$245.4M (up ~14%), q3 2026 non-gaap eps $0.22 vs ~$0.18 expected; GAAP net income ~$18.3M, 2026 guidance Revenue ~$965M-$966M; non-GAAP EPS ~$0.71.
The bottom line: CX vs FRSH
CX and FRSH are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined CX and FRSH exposure against your real portfolio. It is not an investment adviser.
Wondering how CX or FRSH fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Cemex
Ask Walnut's AI anything about CX and see how it fits what you own.
FAQ
What is the difference between CX and FRSH?
+
Cemex (NYSE: CX) is a global building-materials company that makes and sells cement, ready-mix concrete, and aggregates (crushed stone, sand, and gravel), along with related urbanization and infrastructure products. Freshworks Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CX or FRSH the better stock?
+
Neither is universally better. CX is the larger incumbent; FRSH is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CX or FRSH?
+
On forward P/E (as of November 2026), CX trades at 10.35x and FRSH at 14.31x, so CX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CX and FRSH?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CX vs FRSH?
+
CX: Cemex is a deeply cyclical business whose demand swings with construction and infrastructure spending, so a downturn or higher-for-longer interest rates could pressure volumes and pricing. As a Mexico-based operator with an ADR listing, it carries meaningful emerging-market and foreign-exchange risk, with most debt in dollars but large revenue in pesos and other currencies; full-year EBITDA growth guidance of 16% to 17% assumes a fourth-quarter peso rate of roughly 18.25 to 18.50 per dollar. Energy and fuel costs are a major input and can compress margins, and the company recorded goodwill impairments and asset write-downs (about $538 million in 2025). Regulatory, carbon-emission, and geopolitical exposure across its Middle East, Africa, and Latin American footprint add further uncertainty, and the trailing P/E (about 58 as of November 2026, still inflated by a fourth-quarter 2025 loss) leaves little room for execution missteps. In July 2026 the European Commission said construction companies and trade bodies had likely formed a pricing cartel, a regulatory overhang for the European building-materials industry that Cemex operates in. US cement prices slipped about 3% sequentially in the third quarter. The ADR's roughly 20% decline in 2026 through November 20, even after three quarters of earnings beats, shows how quickly sentiment can turn. FRSH: Revenue growth has decelerated from hypergrowth levels into the mid-teens (about 16% in the second quarter of 2026 and about 14% in the third, with fourth-quarter guidance also near 14%), and the shares fell about 20% in the month to November 20, 2026 even after an earnings beat, which shows how the market reacts to slowing growth. The 52-week range is about $6.79 to $15.51. Freshworks competes against much larger, better-capitalized incumbents (ServiceNow, Salesforce, Zendesk, Microsoft, Zoho), and AI could either be a tailwind or commoditize the support-software category if larger platforms bundle comparable automation. The 2026 layoffs signal a bet that AI can do more with fewer people, which carries execution and morale risk. GAAP net income in 2025 was flattened by tax and other items, so headline profitability may not fully reflect underlying earnings power. Stock-based compensation remains meaningful, and the shares have historically been volatile. The Torii acquisition adds integration risk, and because terms were not disclosed its cost and contribution are not yet visible.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CX or FRSH; figures are approximate and dated (as of November 2026). Verify current data before investing.